Evidence map›Paper›PMID 21537083›Full record

ArticleThe Journal of clinical investigation2011

CD8⁺ T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung.

Berber Piet, Godelieve J de Bree, Barbara S Smids-Dierdorp, Chris M van der Loos, Ester B M Remmerswaal, Jan H von der Thüsen, Jan M W van Haarst, Jan P Eerenberg, Anja ten Brinke, Wim van der Bij and 3 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 176 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. CD4Frontiers in immunology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Tissue-resident, memory CD8Frontiers in immunology · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Distribution, phenotype, functional and clinical relevance of CD8Cancer immunology, immunotherapy : CII · 2022
    Article
  20. Review

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Berber PietDepartment of Experimental Immunology, Academic Medical Centre, Amsterdam, Netherlands. b.piet@amc.nl
Godelieve J de Bree
Barbara S Smids-Dierdorp
Chris M van der Loos
Ester B M Remmerswaal
Jan H von der Thüsen
Jan M W van Haarst
Jan P Eerenberg
Anja ten Brinke
Wim van der Bij
Wim Timens
René A W van Lier
René E Jonkers
University of Amsterdam · NLTergooi · NLAcademic Medical Center · NLInstitute for Asthma and Allergy · USSanquin · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human lung T cell compartment contains many CD8⁺ T cells specific for respiratory viruses, suggesting that the lung is protected from recurring respiratory infections by a resident T cell pool. The entry site for respiratory viruses is the epithelium, in which a subset of lung CD8⁺ T cells expressing CD103 (αE integrin) resides. Here, we determined the specificity and function of CD103⁺CD8⁺ T cells in protecting human lung against viral infection. Mononuclear cells were isolated from human blood and lung resection samples. Variable numbers of CD103⁺CD8⁺ T cells were retrieved from the lung tissue. Interestingly, expression of CD103 was seen only in lung CD8⁺ T cells specific for influenza but not in those specific for EBV or CMV. CD103⁺ and influenza-reactive cells preferentially expressed NKG2A, an inhibitor of CD8⁺ T cell cytotoxic function. In contrast to CD103⁻CD8⁺ T cells, most CD103⁺CD8⁺ cells did not contain perforin or granzyme B. However, they could quickly upregulate these cytotoxic mediators when exposed to a type I IFN milieu or via contact with their specific antigen. This mechanism may provide a rapid and efficient response to influenza infection, without inducing cytotoxic damage to the delicate epithelial barrier.

Indexed as

AgedAntigens, CDBlood CellsCD8-Positive T-LymphocytesCytotoxicity, ImmunologicEpitheliumFemaleGene Expression RegulationGranzymesHerpesviridaeHumansImmunophenotypingInfluenza A virusInfluenza, HumanIntegrin alpha1beta1Integrin alpha Chainsalpha E integrinsAntigens, CDGranzymesGZMB protein, humanIntegrin alpha1beta1Integrin alpha ChainsKLRC1 protein, humanNK Cell Lectin-Like Receptor Subfamily CPerforinPore Forming Cytotoxic ProteinsPRF1 protein, human

Identifiers

PMID21537083
PMCPMC3104744
OpenAlexW2131598001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.